8 Recruiting Paroxysmal Nocturnal Hemoglobinuria Phase 3 Clinical Trials
Active phase 3 studies for paroxysmal nocturnal hemoglobinuria enrolling across the USA. Verify eligibility and contact site coordinators.
All Paroxysmal Nocturnal Hemoglobinuria studiesPhase 3 Studies for Paroxysmal Nocturnal Hemoglobinuria
🔵 Active, Not Recruiting Phase3
A Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement Inhibitors
📍 Organizacion Medica de Investigacion (OMI) — Ciudad Autonoma Buenos Aires,
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
A Long-term Safety and Efficacy Study of Danicopan as an Add-on Therapy to Complement Component 5 Inhibitor (C5i) in Participants With PNH
📍 Research Site — Los Angeles, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria
📍 City Of Hope National Med Center — Duarte, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
A Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Not Recently Received or Have Not Received Complement Inhibitor Treatment
📍 The Oncology Institute of Hope & Innovation — Whittier, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Complement Inhibitors
📍 Carolinas Healthcare System — Charlotte, North Carolina
View Study & Checklist ➔ 🟢 Recruiting Phase3
Study of Danicopan as Add-on Treatment to Ravulizumab or Eculizumab in Pediatric Participants With PNH Who Have Clinically Significant Extravascular Hemolysis
📍 Research Site — Saskatoon, Saskatchewan
View Study & Checklist ➔ 🟢 Recruiting Phase3
A Study to Evaluate How Pozelimab + Cemdisiran Combination Therapy Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Whose Current Treatment is Not Working Efficiently
📍 Hospital das Clinicas da FMRP USP — Ribeirão Preto, São Paulo
View Study & Checklist ➔ 🟢 Recruiting Phase3
A Study in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate How Safe Long-term Treatment With Pozelimab + Cemdisiran Combination Therapy is and How Well it Works
📍 Toronto General Hospital — Toronto, Ontario
View Study & Checklist ➔